Three-Year Real World Outcomes of Aflibercept Treatment of Treatment-naive Patients with Neovascular Age-related Macular Degeneration

被引：0
|
作者：
Eleftheriadou, Maria [1 ,2 ]
Gemenetzi, Maria K. [1 ,2 ]
Sivaprasad, Sobha [1 ,2 ]
Hykin, Philip G. [1 ,2 ]
Hamilton, Robin [1 ,2 ]
Tufail, Adnan [1 ,2 ]
Patel, Praveen J. [1 ,2 ]
机构：
[1] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England
[2] UCL, Inst Ophthalmol, London, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2017年 / 58卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
874
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Efficacy of Aflibercept in Treatment-naive Neovascular Age-related Macular Degeneration: Two-Year Real World Outcomes
    Eleftheriadou, Maria
    Vazquez-Alfageme, Clara
    Citu, Maria Cristina
    Crosby-Nwaobi, Roxanne R.
    Sivaprasad, Sobha
    Hykin, Philip
    Hamilton, Robin D.
    Patel, Praveen J.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [2] THREE-YEAR OUTCOMES OF INTRAVITREAL AFLIBERCEPT INJECTION FOR TREATMENT NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Motoki, K.
    Yoshimi, N.
    Masayuki, O.
    Kyoko, F.
    Tomoyuki, C.
    Kazuki, N.
    Kanji, T.
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (02) : E81 - E82
  • [3] Efficacy of Aflibercept in Treatment-naive Neovascular Age-related Macular Degeneration: One-Year Real World Outcomes
    Vazquez-Alfageme, Clara
    Patel, Praveen J.
    Hamilton, Robin
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [4] Three-year Outcomes of Treat and Extend Aflibercept Treatment for Neovascular Age-related Macular Degeneration
    Kataoka, Keiko
    Asai, Keiko
    Tsunekawa, Yuma
    Ito, Yasuki
    Terasaki, Hiroko
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [5] Three-year outcome of aflibercept treatment for Japanese patients with neovascular age-related macular degeneration
    Itagaki, Kanako
    Sekiryu, Tetsuju
    Kasai, Akihito
    Sugano, Yukinori
    Ogasawara, Masashi
    Saito, Masaaki
    [J]. BMC OPHTHALMOLOGY, 2020, 20 (01)
  • [6] Three-year outcome of aflibercept treatment for Japanese patients with neovascular age-related macular degeneration
    Kanako Itagaki
    Tetsuju Sekiryu
    Akihito Kasai
    Yukinori Sugano
    Masashi Ogasawara
    Masaaki Saito
    [J]. BMC Ophthalmology, 20
  • [7] A Trinity regimen with aflibercept for treatment-naive neovascular age-related macular degeneration: 2-year outcomes
    Wakuta, Makiko
    Nomi, Nanami
    Ogata, Tadahiko
    Ota, Manami
    Yamashiro, Chiemi
    Hatano, Makoto
    Yanai, Ryoji
    Tokuda, Kazuhiro
    Kimura, Kazuhiro
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (08) : 1663 - 1670
  • [8] AFLIBERCEPT IN TREATMENT-NAIVE PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: PROSPECTIVE PILOT STUDY
    Udaondo, Patricia
    Garcia-Delpech, Salvador
    Salom, David
    Hervas-Ontiveros, Ana
    Diaz-Cespedes, Ricardo
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [9] Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting
    Eleftheriadou, Maria
    Gemenetzi, Maria
    Lukic, Marko
    Sivaprasad, Sobha
    Hykin, Philip G.
    Hamilton, Robin D.
    Rajendram, Ranjan
    Tufail, Adnan
    Patel, Praveen J.
    [J]. OPHTHALMOLOGY AND THERAPY, 2018, 7 (02) : 361 - 368
  • [10] Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting
    Maria Eleftheriadou
    Maria Gemenetzi
    Marko Lukic
    Sobha Sivaprasad
    Philip G. Hykin
    Robin D. Hamilton
    Ranjan Rajendram
    Adnan Tufail
    Praveen J. Patel
    [J]. Ophthalmology and Therapy, 2018, 7 : 361 - 368
12345